TP53 and posterior cortical atrophy: In metastatic PCa patients, TP53truncating accounts for 34% (179/521) of patients with TP53 mutations and for 33% (182/549) of total TP53 mutations, which was not statistically different compared to patients with localized PCa (p>0.05).